Literature DB >> 1530072

Second-trimester markers of fetal size in schizophrenia: a study of monozygotic twins.

H S Bracha1, E F Torrey, I I Gottesman, L B Bigelow, C Cunniff.   

Abstract

OBJECTIVE: Since the second prenatal trimester is the critical period of massive neural cell migration to the cortex, and fingertip dermal cells migrate to form ridges during this same period, the authors sought to determine whether there are differences in fingertip ridge count in pairs of monozygotic twins discordant for schizophrenia, possibly indicating that a prenatal anatomical insult affected the twins differently.
METHOD: The fingertip dermal ridges of 30 pairs of monozygotic twins (23 pairs in which the twins were discordant for schizophrenia and seven pairs in which both twins were normal) were counted by two persons trained in anthropometric research. Intrapair differences in the counts were then measured, and the differences among the pairs of normal twins were compared with the differences among the pairs discordant for schizophrenia.
RESULTS: The twins discordant for schizophrenia had significantly greater absolute intrapair differences in total finger ridge count and significantly greater percent intrapair differences than the normal twins; i.e., their fingerprints were significantly less "twin-like."
CONCLUSIONS: The study suggests that various second-trimester prenatal disturbances in the epigenesis of one twin in a pair discordant for schizophrenia may be related to the fact that only one of the twins expresses his or her genetic predisposition toward schizophrenia. This is consistent with a "two-strike" etiology of schizophrenia: a genetic diathesis plus a second-trimester environmental stressor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530072     DOI: 10.1176/ajp.149.10.1355

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  18 in total

Review 1.  The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development.

Authors:  Regina Sullivan; Donald A Wilson; Joram Feldon; Benjamin K Yee; Urs Meyer; Gal Richter-Levin; Avital Avi; Tsoory Michael; Michael Gruss; Jörg Bock; Carina Helmeke; Katharina Braun
Journal:  Dev Psychobiol       Date:  2006-11       Impact factor: 3.038

Review 2.  Potential microbial origins of schizophrenia and their treatments.

Authors:  S Hossein Fatemi
Journal:  Drugs Today (Barc)       Date:  2009-04       Impact factor: 2.245

3.  Benign childhood occipital seizures.

Authors:  C P Panayiotopoulos
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

4.  Neonatal origins of schizophrenia.

Authors:  M Cannon; R M Murray
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

5.  Sex-dependent behavioral effects and morphological changes in the hippocampus after prenatal invasive interventions in rats: implications for animal models of schizophrenia.

Authors:  Martina von Wilmsdorff; Ulrich Sprick; Marie-Luise Bouvier; Daniela Schulz; Andrea Schmitt; Wolfgang Gaebel
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

6.  Replication of asymmetry of a-b ridge count and behavioral discordance in monozygotic twins.

Authors:  A C Bogle; T Reed; R J Rose
Journal:  Behav Genet       Date:  1994-01       Impact factor: 2.805

Review 7.  Schizophrenia: D4 receptor elevation. What does it mean?

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1994-05       Impact factor: 6.186

Review 8.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 9.  The neurodevelopmental hypothesis of schizophrenia, revisited.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

Review 10.  Schizophrenia: solving the puzzle.

Authors:  B D Kelly; E O'Callaghan; A Lane; C Larkin
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.